Aurora Cannabis Inc
NASDAQ:ACB

Watchlist Manager
Aurora Cannabis Inc Logo
Aurora Cannabis Inc
NASDAQ:ACB
Watchlist
Price: 4.23 USD -0.94% Market Closed
Market Cap: 230.7m USD

Relative Value

The Relative Value of one ACB stock under the Base Case scenario is 5.02 USD. Compared to the current market price of 4.23 USD, Aurora Cannabis Inc is Undervalued by 16%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ACB Relative Value
Base Case
5.02 USD
Undervaluation 16%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
92
vs Industry
68
Median 3Y
1.2
Median 5Y
2.1
Industry
2.7
Forward
0.9
vs History
vs Industry
16
Median 3Y
-4.8
Median 5Y
-7
Industry
21.6
Forward
-8
vs History
4
vs Industry
Median 3Y
-4.3
Median 5Y
-24.5
Industry
16.9
vs History
vs Industry
Median 3Y
-7.8
Median 5Y
-14.4
Industry
22.9
vs History
74
vs Industry
70
Median 3Y
0.7
Median 5Y
1
Industry
2.3
vs History
85
vs Industry
73
Median 3Y
0.9
Median 5Y
1.8
Industry
3
Forward
0.7
vs History
6
vs Industry
9
Median 3Y
-5.3
Median 5Y
-50
Industry
5.6
vs History
vs Industry
55
Median 3Y
-2.1
Median 5Y
-3.4
Industry
13.4
Forward
4.5
vs History
vs Industry
53
Median 3Y
-1.8
Median 5Y
-2.8
Industry
16.7
Forward
-140.2
vs History
4
vs Industry
54
Median 3Y
-3.4
Median 5Y
-23.6
Industry
16.1
vs History
vs Industry
42
Median 3Y
-9.3
Median 5Y
-27.1
Industry
18.9
vs History
69
vs Industry
77
Median 3Y
0.5
Median 5Y
0.7
Industry
2

Multiples Across Competitors

ACB Competitors Multiples
Aurora Cannabis Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Aurora Cannabis Inc
NASDAQ:ACB
333.2m USD 0.9 -5.7 -1.7 -1.5
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.6 36.7 39.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
491.8B USD 5.3 19.6 16 20.8
CH
Roche Holding AG
SIX:ROG
271.4B CHF 4.4 28.8 12.2 14.3
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP 5.1 31.4 108.9 159.4
US
Merck & Co Inc
NYSE:MRK
274.9B USD 4.3 14.4 10.2 12.1
CH
Novartis AG
SIX:NOVN
218.8B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.3 11.3 13.2
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.9B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
CA
Aurora Cannabis Inc
NASDAQ:ACB
Average P/E: 24.9
Negative Multiple: -5.7
87%
N/A
US
Eli Lilly and Co
NYSE:LLY
54.6
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.6
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.4
15%
1
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.3
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Aurora Cannabis Inc
NASDAQ:ACB
Average EV/EBITDA: 440
Negative Multiple: -1.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.7
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.9
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.2
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
1%
11.3
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Aurora Cannabis Inc
NASDAQ:ACB
Average EV/EBIT: 1 883.6
Negative Multiple: -1.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.3
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.8
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.3
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.4
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.1
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5